Regional Blood Flow Completed Phase 2 / 3 Trials for Moxaverine (DB12251)

IndicationStatusPhase
DBCOND0033542 (Regional Blood Flow)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00709449An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control SubjectsTreatment